SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-149030
Filing Date
2021-05-04
Accepted
2021-05-04 07:54:01
Documents
14
Period of Report
2021-05-04
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d227347d8k.htm   iXBRL 8-K 24006
2 EX-99.1 d227347dex991.htm EX-99.1 147430
6 GRAPHIC g227347g0504042618057.jpg GRAPHIC 5520
  Complete submission text file 0001193125-21-149030.txt   320569

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA rgen-20210504.xsd EX-101.SCH 3080
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE rgen-20210504_lab.xml EX-101.LAB 18906
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rgen-20210504_pre.xml EX-101.PRE 11869
7 EXTRACTED XBRL INSTANCE DOCUMENT d227347d8k_htm.xml XML 3513
Mailing Address 41 SEYON STREET BUILDING 1, SUITE 100 WALTHAM MA 02453
Business Address 41 SEYON STREET BUILDING 1, SUITE 100 WALTHAM MA 02453 7814499560
REPLIGEN CORP (Filer) CIK: 0000730272 (see all company filings)

IRS No.: 042729386 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-14656 | Film No.: 21886040
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences